| X23-10-ZQ199 |
PARP inhibitor EB 47, Purity ≥98%
|
|
| X23-10-ZQ200 |
PARP inhibitor INO-1001, Purity ≥98%
|
|
| X23-10-ZQ201 |
PARP inhibitor PARP-2-IN-1, Purity ≥98%
|
|
| X23-10-ZQ202 |
PARP inhibitor Talazoparib tosylate, Purity ≥98%
|
|
| X23-10-ZQ203 |
PARP inhibitor GeA-69, Purity ≥98%
|
|
| X23-10-ZQ204 |
PARP inhibitor AZ6102, Purity ≥98%
|
|
| X23-10-ZQ205 |
PARP inhibitor MN-64, Purity ≥98%
|
|
| X23-10-ZQ206 |
PARP inhibitor NVP-TNKS656, Purity ≥98%
|
|
| X23-10-ZQ207 |
PARP inhibitor G007-LK, Purity ≥98%
|
|
| X23-10-ZQ208 |
PARP inhibitor NU 1025, Purity ≥98%
|
|
| X23-10-ZQ209 |
PARP inhibitor DR 2313, Purity ≥98%
|
|
| X23-10-ZQ210 |
PARP inhibitor BYK 49187, Purity ≥98%
|
|
| X23-10-ZQ211 |
PARP inhibitor BYK 204165, Purity ≥98%
|
|
| X23-10-ZQ213 |
PARP inhibitor JW 55, Purity ≥98%
|
|
| X23-10-ZQ214 |
PARP inhibitor E7449, Purity ≥98%
|
|
| X23-10-ZQ215 |
PARP agonist Lanifibranor, Purity ≥98%
|
|
| X23-10-ZQ216 |
PARP inhibitor XMD8-87, Purity ≥98%
|
|
| X23-10-ZQ217 |
PARP inhibitor XMD16-5, Purity ≥98%
|
|
| X23-10-ZQ218 |
PARP inhibitor Rucaparib, Purity ≥98%
|
|
| X23-10-ZQ219 |
PARP inhibitor NMS-P515, Purity ≥98%
|
|
